Perelman School of Medicine/ Faculty Search/ Tracey L. Evans

Tracey L. Evans, MD

Associate Professor of Clinical Medicine

Department: Medicine

Contact information

Perelman Center for Advanced Medicine
2 West Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104-4283

Office: 215-662-6681
Fax: 215-615-5888

Education:
BA (Biology and Philosophy)
University of Delaware, Summa Cum Laude, 1992.
MD
University of Pennsylvania, 1996.

Permanent link

Perelman School of Medicine > Faculty > Search

Description of Research Expertise

Thoracic Malignancies
Lung Cancer

Description of Clinical Expertise

Thoracic Malignancies
Lung Cancer

Selected Publications

Xanthopoulos Eric P, Corradetti Michael N, Mitra Nandita, Fernandes Annemarie T, Kim Miranda, Grover Surbhi, Christodouleas John P, Evans Tracey L, Stevenson James P, Langer Corey J, Lee Tony T, Pryma Daniel A, Lin Lilie L, Simone Charles B, Apisarnthanarax Smith, Rengan Ramesh: Impact of PET Staging in Limited-Stage Small-Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Apr 2013.

Schnoll Robert A, Wileyto E Paul, Leone Frank T, Langer Corey, Lackman Richard, Evans Tracey: Is a cancer diagnosis a teachable moment for the patient's relative who smokes? Cancer causes & control : CCC Apr 2013.

Eric P. Xanthopoulos, MD, JD,* Michael N. Corradetti, MD, PhD,* Nandita Mitra, PhD,†Annemarie T. Fernandes, MD,* Miranda Kim, MD, MBA,* Surbhi Grover, MD,*,John P. Christodouleas, MD, MPH,* Tracey L. Evans, MD,‡ James P. Stevenson, MD,‡Corey J. Langer, MD,‡ Tony T. Lee, MD,‖ Daniel A. Pryma, MD,§ Lilie L. Lin, MD,*Charles B. Simone, II, MD,* Smith Apisarnthanarax, MD,* and Ramesh Rengan, MD, PhD: Impact of PET Staging in Limited-Stage Small-Cell Lung Cancer. Journal of Thoracic Oncology 2013.

Evans Tracey: Utility of hypertension as a surrogate marker for efficacy of antiangiogenic therapy in NSCLC. Anticancer research 32(11): 4629-38, Nov 2012.

Ravi Salgia, Benjamin J. Solomon, Alice Tsang Shaw, D. Ross Camidge, Tracey L. Evans, Dong-Wan Kim, Yuankai Shi, Ji-Youn Han, Tommaso Martino De Pas, Sai-Hong Ignatius Ou, Cynthia Huang Bartlett, Keith D. Wilner, Arlene Reisman, Shrividya Iyer: Visual effects in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib. 2012 ASCO Annual Meeting(7596), June 2012.

Anjana Ranganathan, Daniel Schwed-Lustgarten, Charu Aggarwal, Lynn Werner, Drew A. Torigian, Andrea B. Troxel, Tracey L. Evans, James Stevenson, Roger B. Cohen, Bhavesh Vaidya, Chandra Rao, Mark C. Connelly, Steven Albelda, Corey J. Langer: Circulating tumor cells (CTCs) in patients (pts) with small cell lung cancer (SCLC) as a marker of disease burden and therapeutic response, and predictor of disease relapse. 2012 ASCO Annual Meeting(7092), June 2012.

Anna K. Brady, Jonathan D McNeill, Brendan Judy, Tracey L. Evans, Roger B. Cohen, Corey J. Langer, Anil Vachani, Charu Aggarwal: Survival outcome segregated by KRAS mutation status in newly diagnosed stage IV non-small cell lung cancer (NSCLC) patients (pts) treated with first-line chemotherapy. 2012 ASCO Annual Meeting (7595 ), June 2012.

Martin J. Edelman, Ming Tony Tan, Mary J. Fidler, Rachel E. Sanborn, Gregory Alan Otterson, Lecia V. Sequist, Tracey L. Evans, Bryan J. Schneider, Roger Keresztes, John S. Rogers, Jorge Antunez de Mayolo, Michelle Medeiros, Sara L. Zaknoen: A randomized, double-blind, placebo-controlled multicenter phase II study of the COX-2 inhibitor apricoxib (A) in combination with either docetaxel (doc) or pemetrexed (pem) in advanced non-small cell lung cancer (NSCLC) patients (pts) selected by urinary PGE-m suppression. 2012 ASCO Annual Meeting(7546 ), June 2012.

Eblan Michael J, Corradetti Michael N, Lukens J Nicholas, Xanthopoulos Eric, Mitra Nandita, Christodouleas John P, Grover Surbhi, Fernandes Annemarie T, Langer Corey J, Evans Tracey L, Stevenson James, Rengan Ramesh, Apisarnthanarax Smith: Brachial Plexopathy in Apical Non-Small Cell Lung Cancer Treated With Definitive Radiation: Dosimetric Analysis and Clinical Implications. International journal of radiation oncology, biology, physics 85(1): 175-81, Jun 2012.

Dong-Wan Kim, Myung-Ju Ahn, Yuankai Shi, Tommaso Martino De Pas, Pan-Chyr Yang, Gregory J. Riely, Lucio Crinò, Tracey L. Evans, Xiaoqing Liu, Ji-Youn Han, Ravi Salgia, Denis Moro-Sibilot, Sai-Hong Ignatius Ou, Scott N. Gettinger, Yi Long Wu, Silvana Lanzalone, Anna Polli, Shrividya Iyer, Alice Tsang Shaw: Results of a global phase II study with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC). 2012 ASCO Annual Meeting 7533 , June 2012.